Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 1;33(1):73-5.
doi: 10.1016/j.vaccine.2014.09.035. Epub 2014 Oct 8.

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)

Robert T Chen  1 , Baevin Carbery  2 , Lisa Mac  3 , Kenneth I Berns  4 , Louisa Chapman  3 , Richard C Condit  4 , Jean-Louis Excler  5 , Marc Gurwith  6 , Michael Hendry  3 , Arifa S Khan  7 , Najwa Khuri-Bulos  8 , Bettina Klug  9 , James S Robertson  10 , Stephen J Seligman  11 , Rebecca Sheets  12 , Anna-Lise Williamson  13 ; V3SWG
Collaborators, Affiliations

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)

Robert T Chen et al. Vaccine. .

Abstract

Recombinant viral vectors provide an effective means for heterologous antigen expression in vivo and thus represent promising platforms for developing novel vaccines against human pathogens from Ebola to tuberculosis. An increasing number of candidate viral vector vaccines are entering human clinical trials. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to improve our ability to anticipate potential safety issues and meaningfully assess or interpret safety data, thereby facilitating greater public acceptance when licensed.

Keywords: Immunization; Safety; Vaccines; Viral Vector.

PubMed Disclaimer

References

    1. Bonhoeffer J, Kohl K, Chen R, Duclos P, Heijbel H, Heininger U, et al. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI) Vaccine. 2002;21(3–4):298–302. - PubMed
    1. MacDonald NE, Smith J, Appleton M. Risk perception, risk management and safety assessment: what can governments do to increase public confidence in their vaccine system? Biologicals. 2012;40(5):384–8. - PubMed
    1. Amarasinghe A, Black S, Bonhoeffer J, Carvalho SM, Dodoo A, Eskola J, et al. Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization. Vaccine. 2013;31(Suppl 2):B108–14. - PubMed
    1. Chen RT, Hibbs B. Vaccine safety: current and future challenges. Pediatr Ann. 1998;27(7):445–55. - PubMed
    1. Kohl KS, Bonhoeffer J, Chen R, Duclos P, Heijbel H, Heininger U, et al. The Brighton Collaboration: enhancing comparability of vaccine safety data. Pharmacoepidemiol Drug Saf. 2003;12(4):335–40. - PubMed

MeSH terms